EuroEyes International Eye Clinic (HKSE:01846) Cash Flow for Dividends: HK$-20.4 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01846 EuroEyes International Eye Clinic Ltd HKSE:01846
79 GF Score
Price HK$2.48
GF Value HK$5.54
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is EuroEyes International Eye Clinic Cash Flow for Dividends?

EuroEyes International Eye Clinic HKSE:01846 79 Cash Flow for Dividends is HK$-20.4 Mil as of Dec. 2025. GuruFocus rates HKSE:01846 with a GF Score™ of 79/100 and a GF Value™ of HK$5.54 (Significantly Undervalued). The stock has 5 warning signs investors should review.

EuroEyes International Eye Clinic's cash flow for dividends for the six months ended in Dec. 2025 was HK$-10.1 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-20.4 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

EuroEyes International Eye Clinic's quarterly payment of dividends declined from Dec. 2024 (HK$-11.6 Mil) to Jun. 2025 (HK$-10.3 Mil) and declined from Jun. 2025 (HK$-10.3 Mil) to Dec. 2025 (HK$-10.1 Mil).

EuroEyes International Eye Clinic's annual payment of dividends declined from Dec. 2023 (HK$-39.7 Mil) to Dec. 2024 (HK$-27.9 Mil) and declined from Dec. 2024 (HK$-27.9 Mil) to Dec. 2025 (HK$-20.4 Mil).

EuroEyes International Eye Clinic Cash Flow for Dividends Related Terms

EuroEyes International Eye Clinic Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for EuroEyes International Eye Clinic's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EuroEyes International Eye Clinic Cash Flow for Dividends Chart

EuroEyes International Eye Clinic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.84 -33.10 -39.68 -27.85 -20.38

EuroEyes International Eye Clinic Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.03 -16.28 -11.57 -10.27 -10.10
HKSE:01846
79GF Score
EuroEyes International Eye Clinic Ltd HKSE:01846
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EuroEyes International Eye Clinic Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-20.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$-20.4 Mil mean?
EuroEyes International Eye Clinic (HKSE:01846) has a Cash Flow for Dividends of HK$-20.4 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for EuroEyes International Eye Clinic and its competitors.
Is EuroEyes International Eye Clinic's Cash Flow for Dividends too high?
EuroEyes International Eye Clinic's current Cash Flow for Dividends is HK$-20.4 Mil. Overall, EuroEyes International Eye Clinic has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's Cash Flow for Dividends compare to HCA and THC?
EuroEyes International Eye Clinic's Cash Flow for Dividends of HK$-20.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for EuroEyes International Eye Clinic and its competitors. EuroEyes International Eye Clinic's current Cash Flow for Dividends is HK$-20.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.54, compared to a current price of HK$2.48 — trading 55.2% below its estimated fair value. The current Cash Flow for Dividends is HK$-20.4 Mil. EuroEyes International Eye Clinic's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current Cash Flow for Dividends is HK$-20.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?

Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued. The current stock price of HK$2.48 is trading 55.2% below its estimated GF Value™ of HK$5.54. GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.

Key valuation signals for HKSE:01846:

  • Cash Flow for Dividends: HK$-20.4 Mil
  • GF Value™: HK$5.54 vs. price of HK$2.48 (55.2% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EuroEyes International Eye Clinic Business Description

Address Valentinskamp 90, Hamburg, DEU, 20355
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
79GF Score

Get the complete analysis for HKSE:01846

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.48
Price
HK$5.54
GF Value